Marc Jay Zuckerman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophageal and Gastric Varices | 2 | 2021 | 207 | 1.240 |
Why?
|
Irritable Bowel Syndrome | 3 | 2024 | 445 | 1.190 |
Why?
|
Colonoscopy | 9 | 2022 | 1367 | 0.880 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2021 | 1130 | 0.840 |
Why?
|
Bariatrics | 1 | 2021 | 34 | 0.780 |
Why?
|
Gastroplasty | 1 | 2021 | 142 | 0.710 |
Why?
|
Hypertension, Portal | 1 | 2021 | 220 | 0.680 |
Why?
|
Adenoma | 6 | 2022 | 2174 | 0.670 |
Why?
|
Gastrointestinal Diseases | 2 | 2024 | 1170 | 0.640 |
Why?
|
Bismuth | 1 | 2018 | 29 | 0.630 |
Why?
|
Intubation, Gastrointestinal | 2 | 2018 | 152 | 0.630 |
Why?
|
Colonic Polyps | 3 | 2018 | 542 | 0.630 |
Why?
|
Hemostasis, Endoscopic | 1 | 2018 | 35 | 0.630 |
Why?
|
Antacids | 1 | 2018 | 99 | 0.610 |
Why?
|
Mexican Americans | 1 | 2018 | 166 | 0.600 |
Why?
|
Pancreatic Fistula | 1 | 2017 | 146 | 0.560 |
Why?
|
Pleural Diseases | 1 | 2017 | 139 | 0.560 |
Why?
|
Urea | 1 | 2018 | 450 | 0.530 |
Why?
|
Fistula | 1 | 2017 | 220 | 0.520 |
Why?
|
Mexico | 4 | 2024 | 690 | 0.510 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2017 | 504 | 0.490 |
Why?
|
Helicobacter pylori | 1 | 2018 | 382 | 0.490 |
Why?
|
Helicobacter Infections | 1 | 2018 | 386 | 0.490 |
Why?
|
Pleural Effusion | 1 | 2017 | 338 | 0.480 |
Why?
|
Proton Pump Inhibitors | 1 | 2018 | 526 | 0.430 |
Why?
|
Colitis, Ulcerative | 3 | 2021 | 1912 | 0.420 |
Why?
|
Bariatric Surgery | 1 | 2021 | 952 | 0.400 |
Why?
|
Crohn Disease | 3 | 2021 | 2303 | 0.400 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 2425 | 0.320 |
Why?
|
Rome | 1 | 2024 | 28 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3022 | 0.250 |
Why?
|
Flatulence | 1 | 2024 | 20 | 0.250 |
Why?
|
Colorectal Neoplasms | 5 | 2024 | 6773 | 0.240 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3923 | 0.230 |
Why?
|
Texas | 3 | 2022 | 392 | 0.230 |
Why?
|
Ethanolamines | 1 | 2023 | 158 | 0.220 |
Why?
|
Early Detection of Cancer | 6 | 2024 | 3086 | 0.220 |
Why?
|
Endocannabinoids | 1 | 2023 | 116 | 0.210 |
Why?
|
Porphyria, Acute Intermittent | 1 | 2022 | 15 | 0.210 |
Why?
|
Ileus | 1 | 2022 | 58 | 0.210 |
Why?
|
Esophageal Diseases | 1 | 2022 | 166 | 0.190 |
Why?
|
Intestinal Volvulus | 1 | 2021 | 65 | 0.190 |
Why?
|
Ligation | 1 | 2021 | 453 | 0.190 |
Why?
|
Occult Blood | 1 | 2021 | 176 | 0.180 |
Why?
|
Sclerotherapy | 1 | 2021 | 175 | 0.180 |
Why?
|
Antifoaming Agents | 1 | 2019 | 2 | 0.180 |
Why?
|
Simethicone | 1 | 2019 | 15 | 0.170 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7181 | 0.170 |
Why?
|
Plant Preparations | 1 | 2018 | 94 | 0.150 |
Why?
|
Cathartics | 1 | 2018 | 125 | 0.150 |
Why?
|
Acculturation | 1 | 2018 | 182 | 0.150 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2541 | 0.140 |
Why?
|
Breath Tests | 1 | 2018 | 280 | 0.140 |
Why?
|
Humans | 28 | 2024 | 744343 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2017 | 604 | 0.110 |
Why?
|
Intestine, Small | 1 | 2019 | 1241 | 0.110 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4933 | 0.110 |
Why?
|
Middle Aged | 13 | 2024 | 213383 | 0.100 |
Why?
|
Mast Cells | 1 | 2019 | 1544 | 0.100 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2018 | 868 | 0.100 |
Why?
|
Endoscopy | 1 | 2021 | 1785 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2018 | 2453 | 0.100 |
Why?
|
Quality Indicators, Health Care | 2 | 2019 | 1831 | 0.090 |
Why?
|
Male | 14 | 2022 | 350118 | 0.090 |
Why?
|
Stents | 2 | 2022 | 3280 | 0.090 |
Why?
|
Social Class | 1 | 2018 | 1999 | 0.090 |
Why?
|
Female | 15 | 2024 | 380194 | 0.080 |
Why?
|
Aged | 8 | 2022 | 163280 | 0.080 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1076 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3036 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2018 | 5078 | 0.080 |
Why?
|
Prevalence | 3 | 2022 | 15226 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6489 | 0.070 |
Why?
|
Psychophysiologic Disorders | 1 | 1989 | 228 | 0.070 |
Why?
|
Phenotype | 2 | 2021 | 16365 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2022 | 77449 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8340 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2021 | 63114 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 3068 | 0.060 |
Why?
|
Survival Rate | 1 | 2017 | 12788 | 0.050 |
Why?
|
Hydroxymethylbilane Synthase | 1 | 2022 | 7 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4558 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2017 | 4371 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57776 | 0.050 |
Why?
|
Anastomotic Leak | 1 | 2021 | 162 | 0.040 |
Why?
|
Brain | 2 | 2024 | 26385 | 0.040 |
Why?
|
Risk Factors | 4 | 2021 | 72290 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12745 | 0.040 |
Why?
|
Young Adult | 3 | 2022 | 56430 | 0.040 |
Why?
|
Medically Uninsured | 1 | 2024 | 853 | 0.040 |
Why?
|
Gastrointestinal Motility | 1 | 2019 | 225 | 0.040 |
Why?
|
Anastomosis, Surgical | 1 | 2021 | 987 | 0.040 |
Why?
|
Adult | 4 | 2023 | 214055 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1643 | 0.040 |
Why?
|
Mass Screening | 2 | 2024 | 5255 | 0.040 |
Why?
|
Health Education | 1 | 2024 | 1056 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 23338 | 0.040 |
Why?
|
Cecum | 1 | 2017 | 237 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2021 | 594 | 0.030 |
Why?
|
United States | 3 | 2018 | 69872 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39050 | 0.030 |
Why?
|
Cell Count | 1 | 2019 | 1856 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2019 | 1590 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2022 | 1063 | 0.030 |
Why?
|
Feces | 1 | 2021 | 1401 | 0.030 |
Why?
|
Adolescent | 2 | 2021 | 85781 | 0.030 |
Why?
|
Patient Compliance | 1 | 2024 | 2684 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 1182 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2902 | 0.030 |
Why?
|
Prospective Studies | 1 | 2017 | 53288 | 0.030 |
Why?
|
Colon | 1 | 2020 | 1772 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2021 | 1848 | 0.030 |
Why?
|
Tumor Burden | 1 | 2017 | 1915 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 3913 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7149 | 0.020 |
Why?
|
Gastroenterology | 1 | 2017 | 536 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4644 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 4297 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9849 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14722 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9959 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
Smoking | 1 | 2018 | 8987 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18370 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29786 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40075 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17446 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25043 | 0.010 |
Why?
|